Morphine-Bupivacaine Injectable Recalled for Non-Sterility
Med Shop Total Care Inc. is recalling morphine-bupivacaine injectable in prefilled syringes of multiple strengths due to non-sterility. The affected product was distributed to Texas and Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA has classified this as a Class I recall of an injectable drug due to non-sterility, which meets the "Severe" threshold as non-sterile injectables pose significant risk of infection and serious harm. Although no reported illnesses or injuries are stated in the source text, the agency's own Class I classification and the nature of the hazard (non-sterility in an injectable product) warrant a score of 4.
Plain-English summary
Med Shop Total Care Inc. is recalling morphine-bupivacaine injectable in prefilled syringes available in 21 mL, 22 mL, 23 mL, 41 mL, and 43 mL sizes in multiple strength combinations. The recall was initiated due to non-sterility concerns.
The affected product was distributed to Texas and Puerto Rico. Multiple lot numbers are included in the recall, with best-by dates ranging from October 27, 2020 to October 30, 2020. The affected lots span various strength formulations of the morphine-bupivacaine combination.
This is a Class I recall, meaning the product may cause serious adverse health consequences or death. The recalling firm initiated this recall voluntarily on October 5, 2020. Healthcare providers and patients who have received or are in possession of affected units should discontinue use and contact Med Shop Total Care Inc. at 470 East Loop 281, Longview, TX 75605.
The recalled product
- Product
- MORPHINE-BUPIVACAINE PF INJECTABLE 21 mL, 22 mL, 23 mL, 41 mL and 43 mL syringes in various strengths: a) 20MG/ML-40MG/ML, b) 15MG-30MG/ML, c) 5MG/ML-20MG/ML, d) 2MG-30MG/ML, e) 20MG-5MG/ML, f) 15MG-5MG/ML, g) 5MG-2MG/ML, h) 5MG-11MG/ML, i) 20MG-6MG/ML, j) 10MG-10MG/ML, k) 6MG-4.
- Manufacturer
- Med Shop Total Care Inc.
- Category
- Drug — Injectable / Parenteral
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: a) 09282020@62
- BUD 10/27/2020
- 09302020@25
- BUD 10/29/2020
- b) 09292020@56
- c) 09292020@58
- d)09292020@60
- e) 09292020@66
- 09292020@73
- f) 09292020@70
- g) 09292020@71
- h) 09292020@77
- i) 09302020@20 j) 09302020@33
- k) 09302020@48
- l) 09302020@61
- m) 09302020@66
- n) 09302020@70
- o) 09302020@26
- p) 10012020@8
- q) 10022020@20
Distribution
Part of a larger recall action
This product is one of 14 recalled by Med Shop Total Care Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Med Shop Total Care Inc.
See all →- SevereMorphine-Bupivacaine-Ketamine Injectables Recalled for Non-Sterility
FDA (Drugs) · 2021-08-18
- SevereHydromorphone HCL-Bupivacaine HCL Injectable Recalled for Non-Sterility
FDA (Drugs) · 2021-08-18
- SevereInjectable morphine-hydromorphone-bupivacaine mixture recalled for non-sterility
FDA (Drugs) · 2021-08-18
- SevereInjectable Drug Recalled for Non-Sterility Risk
FDA (Drugs) · 2021-08-18
- SevereInjectable Drug Syringes Recalled for Non-Sterility
FDA (Drugs) · 2021-08-18
Same hazard · non sterility
See all →- SevereChloraPrep One-Step Antiseptic Solution Recall Due to Sterility Concerns
FDA (Drugs) · 2026-07-01
- SevereChloraPrep One-Step Topical Antiseptic Recalled for Non-Sterility
FDA (Drugs) · 2026-07-01
- SevereLSL Healthcare Infant Central Line Dressing Change Kit Recalled
FDA (Devices) · 2026-04-29
- HighLSL Healthcare Central Line Dressing Change Kit Recalled for Non-Sterility
FDA (Devices) · 2026-04-29
- HighLSL Healthcare Wound Closure Tray Model 7554 Recalled for Non-Sterility
FDA (Devices) · 2026-04-29